We have updated our privacy policy. If you have any question, contact us at privacy@scicrunch.org. Dismiss and don't show again

Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

The APC/C maintains the spindle assembly checkpoint by targeting Cdc20 for destruction.

Nature cell biology | Dec 1, 2008

The spindle assembly checkpoint (SAC) is required to block sister chromatid separation until all chromosomes are properly attached to the mitotic apparatus. The SAC prevents cells from entering anaphase by inhibiting the ubiquitylation of cyclin B1 and securin by the anaphase promoting complex/cyclosome (APC/C) ubiquitin ligase. The target of the SAC is the essential APC/C activator Cdc20. It is unclear how the SAC inactivates Cdc20 but most current models suggest that Cdc20 forms a stable complex with the Mad2 checkpoint protein. Here we show that most Cdc20 is not in a complex with Mad2; instead Mad2 is required for Cdc20 to form a complex with another checkpoint protein, BubR1. We further show that during the SAC, the APC/C ubiquitylates Cdc20 to target it for degradation. Thus, ubiquitylation of human Cdc20 is not required to release it from the checkpoint complex, but to degrade it to maintain mitotic arrest.

Pubmed ID: 18997788 RIS Download

Mesh terms: Amino Acid Motifs | Anaphase-Promoting Complex-Cyclosome | Calcium-Binding Proteins | Cdc20 Proteins | Cell Cycle Proteins | Chromatography, Gel | HeLa Cells | Humans | Lysine | Mad2 Proteins | Mutant Proteins | Protein Binding | Protein Processing, Post-Translational | Protein-Serine-Threonine Kinases | Repressor Proteins | Spindle Apparatus | Ubiquitin-Protein Ligase Complexes | Ubiquitination

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: Cancer Research UK, Id: A3211
  • Agency: Cancer Research UK, Id: A7397
  • Agency: Cancer Research UK, Id: C29/A3211

BioGRID (Data, Interactions)

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.